A phase I/II study of oral clofarabine plus low‐dose cytarabine in previously treated acute myeloid leukaemia and high‐risk myelodysplastic syndrome patients at least 60 years of age
暂无分享,去创建一个
E. Estey | B. Wood | J. Pagel | T. Gooley | R. Walter | P. Becker | P. Hendrie | B. Scott | V. Sandhu | S. Buckley | R. Mawad | Kelly M. Smith | Carol Dean | B. Wood | C. Dean